There are now around 2.81 million people in England diagnosed with either Type 1 or Type 2 diabetes, and it is estimated that there are a further 940,000 people with undiagnosed Type 2 diabetes and another seven million people are at risk of developing diabetes.

Find your nearest AHSN



In south London there are currently 159,819 people identified as having either Type 1 or Type 2 diabetes. Diabetes UK estimates that the NHS is already spending around £10 billion a year on diabetes and managing the growing impact of diabetes is a major clinical challenge.

We are working to share, adopt, develop and implement innovative ways of improving health outcomes for people with Type 1 and Type 2 diabetes, with an emphasis of minimising the impact of diabetes on their lives.


“Over the next 10 years, the NHS will offer a ‘digital first’ option for most citizens according to the plan. A key milestone in this drive is the current national rollout of the NHS App.” - Tara Donnelly


How can innovation help?

Firstly, we aim to explore how digital can provide more flexibility and potentially improve access to self-directed learning for clinicians to develop a standardised approach to care planning that achieves good outcomes for people with type 1 diabetes and increases the efficiency of services.

We also recognise that face to face approaches do not always work for everyone and aim to discover and promote apps that can empower more people to self-manage their diabetes, reducing the burden on clinicians and the NHS.

Desired impact/outcomes 

The desired outcomes of this innovation exchange are:

  • Linking innovators working on innovations or tools that help prevent or manage diabetes to external stakeholders and NHS trusts that might benefit from their innovation in south London.
  • Improving accessibility to information that supports self-management and care of people living with Type 1 and Type 2 diabetes in south London
  • Scaling digital flexible learning resources to support management and self-care for people living with diabetes.